Stock profile

Denka Company Limited(4061.T)

Country: JapanSector: Basic MaterialsIndustry: ChemicalsExchange: JPX
P/E TTM
19.7
History
P/E NTM
21.2
Market cap
310.15B
Currency JPY
KvantraRanki46
Value26
Quality43
Momentum83
Current price
3,586.00-0.28%
Benchmarks

No price history available.

Key financial summary

Financials in JPY
2020202120222023202420252026TTM2027E
Total revenue¥m380,803354,391384,849407,559389,263400,251384,247N/AN/A
Operating profit¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net profit¥m22,70222,78426,01212,76911,948-12,30015,695N/AN/A
EPS reported¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Capex per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flow¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Book value equity¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Book value per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)¥LockedLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in JPY
2020202120222023202420252026TTM2027E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Denka Company Limited, a Tokyo, Japan-based entity founded in 1915, operates internationally as a manufacturer and supplier of a wide array of organic and inorganic materials, electronic components, and pharmaceutical products. Its Electronics & Innovative Products division delivers specialized solutions like conductive agents essential for lithium-ion batteries, advanced thermal management materials, various substrates, high-performance ceramics, and adhesive films and tapes. The Life Innovation segment is dedicated to the production of influenza vaccines, the development of rapid diagnostic test kits for infectious diseases such as the novel coronavirus, and the provision of macromolecular sodium hyaluronate preparations. Within its Elastomers & Infrastructure Solutions division, the company offers functional elastomers, cement and specialized cement additives, agricultural fertilizers, and corrugated piping designed for farming applications. Lastly, the Polymer Solutions division focuses on polymer-based offerings, including styrene resins, sheets used for food packaging, synthetic fibers utilized in wigs and hairpieces, and other chemical compounds like poval. The company, initially incorporated as Denki Kagaku Kogyo Kabushiki Kaisha, officially adopted its current name, Denka Company Limited, in October 2015.

SectorBasic Materials
IndustryChemicals
CountryJapan
Trades inJPY

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Denka Company Limited (4061.T)

4061.T · JPX · Basic Materials
3,586.00-0.28%
Sign up to track this stock

No price history available.

KvantraRank46
P/E TTM19.7
P/E NTM21.2
Market cap310.15B
KvantraRank46 / 100
Value
26
Quality
43
Momentum
83
Financialsin JPY
20242025TTM2026
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Denka Company Limited, a Tokyo, Japan-based entity founded in 1915, operates internationally as a manufacturer and supplier of a wide array of organic and inorganic materials, electronic components, and pharmaceutical products. Its Electronics & Innovative Products division delivers specialized solutions like conductive agents essential for lithium-ion batteries, advanced thermal management materials, various substrates, high-performance ceramics, and adhesive films and tapes. The Life Innovation segment is dedicated to the production of influenza vaccines, the development of rapid diagnostic test kits for infectious diseases such as the novel coronavirus, and the provision of macromolecular sodium hyaluronate preparations. Within its Elastomers & Infrastructure Solutions division, the company offers functional elastomers, cement and specialized cement additives, agricultural fertilizers, and corrugated piping designed for farming applications. Lastly, the Polymer Solutions division focuses on polymer-based offerings, including styrene resins, sheets used for food packaging, synthetic fibers utilized in wigs and hairpieces, and other chemical compounds like poval. The company, initially incorporated as Denki Kagaku Kogyo Kabushiki Kaisha, officially adopted its current name, Denka Company Limited, in October 2015.

SectorBasic Materials
IndustryChemicals
CountryJapan
Trades inJPY

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans